What does the evidence say about Royal Jelly Lipid Profile Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Royal Jelly Lipid Profile Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Cardiovascular diseases and diabetes are associated with significant mortality, morbidity, and economic burden, highlighting the need for alternative preventive strategies. [Norouzzadeh M (2025); evidence level 1] - Honey bee products, including honey, royal jelly, and propolis, are considered potential interventions for managing cardiometabolic risk factors. [Norouzzadeh M (2025); evidence level 1] - Random-effect pairwise analysis combined trial findings, while dose-response and influence analyses assessed result robustness. [Norouzzadeh M (2025); evidence level 1] - Nevertheless, the health implications associated with the prolonged dietary supplementation of royal jelly have yet to be elucidated extensively. [Cho KH (2024); evidence level 4] - Interestingly, female zebrafish were found to be more biased, with a significant 17% ( p p w / w ) royal jelly, compared to the male zebrafish. [Cho KH (2024); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.